Bafilomycin A1 (Baf-A1) Mechanism of Action: V-ATPase Inhibition in Cancer Cell Research

Bafilomycin A1 (Baf-A1) MOA:Targeting V-ATPase/Autophagy for Oncology Research

🎯 check Bafilomycin A1 (Baf-A1) product page

Bafilomycin A1 is a potent V-ATPase inhibitor. It affects PI3K/Akt/mTOR and AMPK signaling pathways by preventing lysosomal acidification and blocking autophagosome-lysosome fusion, thereby inhibiting late-stage autophagy and viral replication, and promoting apoptosis.

Primary Applications and Mechanism of Action